Skip to Content

Carlton Fields Adds Litigator to Mass Tort and Product Liability Practice

Tampa, Fla. – Carlton Fields is pleased to announce that Andre A. Revaz has joined the firm as an associate in Tampa.

Revaz is a member of Carlton Fields’ national Mass Tort and Product Liability Practice, which defends Fortune 100 manufacturers in high-stakes litigation in state and federal courts nationwide. Firm attorneys serve as national, local, and regional counsel in a variety of mass tort and class action cases involving consumer products, pharmaceuticals, medical devices, and other products and industries. The firm maintains lead roles in virtually every mass tort portfolio of cases pending in Florida as well as lead or important roles in cases pending in California and in other jurisdictions and across the country.

Revaz is well-versed in all aspects of litigation, including case management, motion practice, depositions, discovery, and trial preparation. His experience includes handling various tort matters, including a focus on fact and expert discovery in general tort and medical negligence matters. He also has experience in the public sector, serving as a Florida Gubernatorial Fellow with the Executive Office of Gov. Ron DeSantis and interning with the Polk County Sheriff’s Office.

Revaz earned his J.D., cum laude, from University of Florida Levin College of Law and his B.A., cum laude, in Political Science with a minor in Leadership from University of Florida.



The information on this website is presented as a service for our clients and Internet users and is not intended to be legal advice, nor should you consider it as such. Although we welcome your inquiries, please keep in mind that merely contacting us will not establish an attorney-client relationship between us. Consequently, you should not convey any confidential information to us until a formal attorney-client relationship has been established. Please remember that electronic correspondence on the internet is not secure and that you should not include sensitive or confidential information in messages. With that in mind, we look forward to hearing from you.